Evidence map›Paper›PMID 40740370›Full record

ArticleFrontiers in public health2025

Stakeholder perspectives and the challenges in implementing hepatitis C elimination policy in Pakistan.

Naeem Asim, Wenbiao Hu, Liang Qiao, Usman Ali Khan, Zaka Un Nisa

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Naeem AsimIslamia University of Bahawalpur, Bahawalpur, Pakistan.
Wenbiao HuQueensland University of Technology, Brisbane, QLD, Australia.
Liang QiaoThe University of Sydney, Darlington, NSW, Australia.
Usman Ali KhanPrimary and Secondary Healthcare Department, Lahore, Punjab, Pakistan.
Zaka Un NisaQuaid-i-Azam University, Islamabad, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite significant achievements in combating hepatitis C (HCV), HCV remains a major global public health issue with approximately 71 million cases and 400,000 deaths annually. The international community has taken several important steps for HCV control, including the Global Health Sector Strategy (2016-2021), the Global Hepatitis Action Plan (2011), and the United Nations Sustainable Development Goals (UN-SDGs) for 2030. However, achieving the World Health Assembly's goal of eliminating HCV by 2030 treating 90% of all infected individuals remains a significant challenge, particularly in Pakistan. This study delves into the perspectives of key stakeholders involved in the hepatitis elimination policy and its implementation in Pakistan, identifying barriers to effective policy execution and highlighting motivating factors. Through a phenomenological approach, interviews were conducted with ten key informants, including policymakers, clinicians and provincial hepatitis program personnel. Thematic analysis uncovered several critical themes: perceptions of hepatitis and elimination policies, the feasibility of achieving elimination goals, international collaborations, policy development, gaps in epidemiological data, and the influence of political contexts. The findings emphasize the need for a robust national database, stronger political commitment, better resource allocation, and a more integrated healthcare system. Drawing on successful models, such as Egypt, the study suggests that Pakistan must adopt comprehensive and coordinated strategies to meet the WHO targets and eliminate hepatitis by 2030.

Indexed as

Disease EradicationHealth PolicyHepatitis CStakeholder ParticipationHumansInterviews as TopicPakistanPolicy MakingcontroleliminationHCVhepatitisPakistanpolicy

Identifiers

PMID40740370
PMCPMC12307338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.